Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Politicians who traded PBYI
Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.
- Trades
- 2
- Filings
- 1
- Politicians
- 1
- Buys / sells
- 1 / 1
- Estimated volume
- $16.0K
- Sum of range midpoints
| Politician | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
 Donna E. Shalala House · FL | 2 | 1 / 1 | $16.0K | May 15, 2019 | Apr 27, 2020 |
Trades
Reported trades in Puma Biotechnology, Inc., newest filings first.
| Politician | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
Donna E. Shalala House · FL | PBYIPuma Biotechnology Inc | Sell | Self | May 15, 2019 | Apr 27, 2020 | 348 daysLate | $1K-$15K | Filing |
Donna E. Shalala House · FL | PBYIPuma Biotechnology Inc | Buy | Self | Jan 23, 2019 | Apr 27, 2020 | 460 daysLate | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.